This device series opens up a new era for non-invasive liver disease diagnosis. It is suitable for the quantitative diagnosis of liver ﬁbrosis and fatty liver caused by various chronic liver diseases. It supports early detection, diagnosis, treatment, and rehabilitation of various chronic liver diseases. Recommend by global liver disease guidelines, non-invasive quantitative analysis of ﬁbrosis is the ﬁrst step in chronic liver disease assessment.
Quantitative analysis of liver stiffness
Provide quantitative detection of liver stiffness and liver fibrosis stage by transient elastography technology
Quantitative analysis of liver steatosis
The severity of liver steatosis can be quantitatively evaluated by LiSA (Liver Ultra-Sound Attenuation) technology.
Advanced ViTE (Visualized Transient Elastography)
Wide range of clinical applications
It is applicable to the screening, diagnosis, monitoring, and treatment assessment of liver fibrosis and steatosis due to various reasons. Especially during early stage.
Nonalcoholic fatty liver disease
Alcoholic liver disease
Chronic hepatitis B
Chronic hepatitis C
Drug-induced liver injury
Autoimmune liver disease
Biliary tract disease
Various ultrasound solutions*
· Professional ultrasound probe to facilitate the examination of ascites, etc.
· Dedicated ultrasound guided puncture to improve the accuracy of biopsy
· Excellent ultrasound image and function enable comprehensive assessment of liver morphology and hemodynamics.